Judges for the Maryland Appellate Court uphold a state-imposed ban on the sale of "hemp-derived" intoxicants containing delta-8-THC, delta-10-THC, and other synthetically produced cannabinoids.
Study shows "clinically important" improvements in pain, anxiety, sleep, and quality of life for complex regional pain syndrome patients following cannabis treatment.